CVS HEALTH Corp (CVS)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 98,915 | 94,588 | 95,428 | 91,234 |
| Restructuring charges | - | - | 1,169 | - |
| Loss on assets held for sale | - | - | - | - |
| Health care costs | 31,317 | 29,135 | 29,922 | 27,853 |
| Operating expenses | 11,212 | 11,022 | 10,557 | 10,338 |
| Cost of products sold | 54,005 | 51,057 | 52,948 | 49,998 |
| Total operating costs | 96,534 | 91,214 | 94,596 | 88,189 |
| Operating income | 2,381 | 3,374 | 832 | 3,045 |
| Interest expense | 763 | 785 | 752 | 732 |
| Other income | 29 | 28 | 25 | 24 |
| Income before income tax provision | 1,647 | 2,617 | 105 | 2,337 |
| Income tax provision | 634 | 835 | 34 | 569 |
| Net income | 1,013 | 1,782 | 71 | 1,768 |
| Net (income) loss attributable to noncontrolling interests | -8 | 3 | -16 | -2 |
| Net income attributable to cvs health | 1,021 | 1,779 | 87 | 1,770 |
| Basic (in dollars per share) | 0.81 | 1.41 | 0.07 | 1.41 |
| Basic (in shares) | 1,266,000,000 | 1,261,000,000 | 1,259,000,000 | 1,256,000,000 |
| Diluted (in dollars per share) | 0.8 | 1.41 | 0.07 | 1.41 |
| Diluted (in shares) | 1,270,000,000 | 1,264,000,000 | 1,259,000,000 | 1,259,000,000 |